Nanopath announced that it closed a Series A funding round to support its biosensing platform for diagnostics. Cambridge, Massachusetts–based Nanopath intends to use the funds to back the development and commercialization of its platform that aims to transform how women’s pelvic and gynecologic infections are diagnosed. The company designed its novel approach to simultaneously characterize […]